(Q36288354)

13 August 2017

1 reference

title

Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease (English)

1 reference

13 August 2017

1 reference

3

Foëx P

1 reference

13 August 2017

Biccard BM

1

1 reference

PubMed ID

16229696

13 August 2017

Sear JW

series ordinal

2

1 reference

PubMed ID

16229696

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

60

1 reference

13 August 2017

11

1 reference

13 August 2017

1106-1114

1 reference

Does preoperative coronary angioplasty improve perioperative cardiac outcome?

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Statins and their role in vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

The role of statins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Myocardial infarction after noncardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Early statin initiation and outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction National Registry of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04405.X

10.1111/J.1365-2044.2005.04405.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16229696